Chemotherapy-free treatment of recurrent advanced ovarian cancer: myth or reality?

Advanced ovarian cancer remains a leading cause of death from gynecologic malignancy. Surgery and, in most cases, platinum-based chemotherapy with or without maintenance with bevacizumab and/or poly-ADP ribose polymerase inhibitors (PARPi) represent the mainstay of treatment, but the disease typical...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Cristiana, Ferreira da Silva, Filipa, Sousa, Isabel, Nave, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086454/
https://www.ncbi.nlm.nih.gov/pubmed/36446409
http://dx.doi.org/10.1136/ijgc-2022-003719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086454/
https://www.ncbi.nlm.nih.gov/pubmed/36446409
http://dx.doi.org/10.1136/ijgc-2022-003719

Ejemplares similares